How to Keep The Weight Off After Stopping Ozempic or Wegovy

Written and medically reviewed by Hina Zaman, MD, board certified in family medicine by the American Board of Family Medicine. Last reviewed October 4, 2026.

If you’re trying to figure out how to keep the weight off after stopping Ozempic or Wegovy, start with the honest version: most people do regain, and the speed surprises them. The useful news is that there are two approaches with real evidence behind them, and one of them finally got a proper clinical trial in 2026.

Here’s the short answer. The most reliable way to hold your weight is to stay on some amount of medication, often a lower dose than you lost weight on. The second approach, coming off completely and defending the loss with food, strength training, and close monitoring, works for some people but has much weaker evidence. Knowing which one you’re choosing, and why, matters more than any single diet tip.

What actually happens to your weight after stopping Ozempic

The pattern in plain terms: appetite comes back within a few weeks, intake creeps up, and weight follows. In the 2026 meta-analysis of 37 studies and 9,341 adults published in The BMJ, people regained an average of 0.4 kg per month after stopping any weight-loss medication. For semaglutide and tirzepatide specifically, the drugs in Ozempic, Wegovy, Mounjaro, and Zepbound, it was 0.8 kg per month. That’s roughly 1.8 pounds every month, or about 10 kg in the first year.

The same analysis projected a return to starting weight in about a year and a half. Blood pressure, A1C, cholesterol, and triglycerides all drifted back toward baseline too, within roughly 1.4 years.

The older trial data lines up. In the STEP 1 extension, participants who’d lost 17.3 percent of their body weight on semaglutide regained about two-thirds of it in the year after treatment ended. They were still down 5.6 percent from where they started, which is not nothing. But two-thirds came back.

Why your body pushes back this hard

These medications work by copying a gut hormone that tells your brain you’re full and slows how fast your stomach empties. Stop the medication and that signal fades over a few weeks. Semaglutide takes around six weeks to mostly clear your system, so the hunger doesn’t hit all at once. It builds.

What you’re feeling isn’t weakness. It’s your appetite returning to its old setting in a body that now needs fewer calories than it did before, because it’s smaller. That’s a real metabolic headwind, not a character flaw.

The two approaches that actually work

Almost everything written about this topic jumps straight to protein and resistance training. Those matter, and we’ll get to them. But the first decision is bigger: are you staying on treatment in some form, or coming off it entirely?

Approach 1: Stay on the lowest dose that holds your weight

This is the approach with the strongest evidence, and it got much stronger this year. The SURMOUNT-MAINTAIN trial, published in The Lancet in June 2026, did something nobody had properly tested. After 60 weeks of losing weight on tirzepatide at the highest dose they tolerated, participants were split into three groups: stay on the full dose, step down to 5 mg, or stop entirely.

At week 112, weight change from the original starting point was 22.4 percent down for those who stayed on the full dose, about 17 percent down for those who stepped down to 5 mg, and 10.1 percent down for those who stopped. The step-down group held about 70 percent of their loss. The stop group needed rescue treatment far more often: 67 percent of them, compared with 25 percent on the lower dose and 8 percent on the full dose.

So a lower dose isn’t as good as staying put. It’s a lot better than nothing. That’s a genuinely useful middle option if cost is your problem, if side effects were wearing you down, or if the full dose always felt like more than you needed.

Family physicians writing in American Family Physician this February laid out three ways to do this in practice:

• Dose de-escalation. Step the dose down gradually instead of quitting at your top dose, so appetite doesn’t come roaring back all at once.
• Interval dosing. Stretch the time between injections, often to every 10 to 15 days first, sometimes out to every 21 days. These drugs have a long half-life, so the appetite control doesn’t vanish between doses.
• Adding an oral medication. Pair a reduced injectable dose with an older oral option like phentermine-topiramate or naltrexone-bupropion to cover the appetite rebound.

Switching is also on the table. Some people do better on tirzepatide than semaglutide or the other way around, and insurance sometimes covers one and not the other. If cost is the barrier, the oral Wegovy pill has a lower self-pay starting price than the injection. Deciding which GLP-1 medication fits your situation is worth a real conversation rather than a guess.

Major guidelines now point the same direction. The Obesity Association, a division of the American Diabetes Association, published new Standards of Care in January 2026 recommending that obesity medications continue after you reach your goal, because stopping tends to bring the weight and the cardiometabolic problems back.

Approach 2: Come off fully, with a plan to defend the loss

Sometimes stopping completely is the right call. Pregnancy plans, a side effect you can’t live with, surgery coming up, or a budget that simply won’t stretch. People do hold meaningful weight loss after coming off. But I want to be straight with you about what the evidence does and doesn’t say here.

The BMJ analysis looked specifically at whether behavioral support slowed regain. It didn’t. Weight came back faster after stopping medication than after finishing a diet and exercise program, by about 0.3 kg per month, no matter how much weight had been lost. People who got behavioral support alongside their medication lost more weight, but they didn’t regain any slower afterward.

Read that again, because it’s the opposite of what most articles on this topic tell you. There’s no trial showing that protein and the gym will hold your weight after you stop. What the researchers suspect is that when medication does the appetite work for you, you never build the habits that carry the loss on their own.

That’s an argument for building those habits while you’re still on the medication, not after. It’s also an argument for a trigger plan, which is the part people skip.

Comparing the two side by side

	Stay on a reduced dose	Stop completely
Evidence quality	Randomized trial, 2026	No trial showing it prevents regain
Typical result	Holds roughly 70% of loss at a 5 mg step-down	Highly variable, average is substantial regain
Monthly cost	Lower than full dose, not zero	Zero
Side effects	Usually milder at lower doses	Resolve
Best fit	Cost or tolerability is the problem, not the drug	Pregnancy plans, a side effect you can’t tolerate, or a firm personal decision

Why real-world results look better than the trials

Here’s the part that should give you some genuine optimism. Cleveland Clinic published a study of 7,938 adults in March 2026 who started semaglutide or tirzepatide and then stopped within three to twelve months. These weren’t trial volunteers. They were ordinary patients in Ohio and Florida.

Patients treated for obesity had lost 8.4 percent of their body weight before stopping, and regained an average of just 0.5 percent a year later. Forty-five percent either kept losing or stayed exactly where they were. Among patients with type 2 diabetes, 56 percent held steady or kept losing.

Why so much better than the trials? Because real patients don’t just stop and accept it. Within a year, 27 percent had switched to a different medication, 20 percent had restarted their original one, and 14 percent were working with a dietitian or exercise specialist. Fewer than 1 percent had bariatric surgery.

In other words, the people who held their weight mostly didn’t white-knuckle it. They kept treating the problem, they just changed how. The main reason they’d stopped in the first place wasn’t that the drug failed. It was cost and insurance coverage, with side effects a distant second.

Protect your muscle, not just the number on the scale

When you lose weight fast, some of it is muscle. In the STEP 1 trial, of the roughly 13.6 kg participants lost, 8.3 kg was fat and 5.3 kg was lean body mass. The AFP editorial puts the figure as high as 40 percent of total weight loss being lean mass.

Now the uncomfortable part: when weight comes back, it comes back mostly as fat. Lose 20 pounds of mixed tissue, regain 20 pounds of fat, and you weigh the same while being metabolically worse off than when you started. Repeat that a few times and you’re heading toward what’s called sarcopenic obesity.

This is the real reason protein and strength training matter. Not because they’ll hold your weight on their own, but because they change what you lose and what you keep.

The 2025 joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society gives specific targets:

• Protein: 1.2 to 1.6 g per kg of body weight daily during active weight loss, or an absolute target of 80 to 120 g per day. Eat the protein first at each meal, before the rice or the roti.
• Strength training: at least three sessions a week. The advisory is explicit that extra protein alone won’t preserve muscle without it.
• Aerobic activity: at least 150 minutes a week at moderate intensity, which matches the CDC’s adult guidelines.

A note for my South-Asian patients in Murphy and Plano. Body composition matters more for you, not less. South-Asian adults carry more visceral fat at the same body weight and face diabetes risk at a lower BMI, which is why the American Diabetes Association recommends screening at a BMI of 23 rather than 25. Losing muscle while regaining fat hits your metabolic risk harder than the scale suggests. A body composition scan in our Murphy office takes a few minutes and tells you what the scale can’t.

Before you stop: what to sort out with your doctor

Picture a 47-year-old mom in Plano. She’s down 32 pounds on Wegovy, her blood pressure is finally normal, and her employer just changed insurance plans. The new plan doesn’t cover weight-loss medication. She has three pens left in the fridge and no plan.

That’s the most common version of this story I see, and it’s almost always driven by coverage rather than by anything medical. It’s also the version where a single appointment changes the outcome, because there are real options between full dose and nothing.

Things to work through before your last dose:

• Is a lower dose or longer interval possible? Ask directly. Many people don’t know this is an option.
• Was it cost? Manufacturer savings programs, prior authorization help, and switching products can all move the number. Our office handles this paperwork regularly.
• Was it side effects? If side effects were the reason you stopped, a lower dose or a different drug in the class often solves it without giving up the benefit.
• Your other medications. If you take insulin, a sulfonylurea, or blood pressure medication, those doses may have been lowered while you were losing. They may need to go back up as weight returns. Don’t leave that unmonitored.
• Pregnancy plans. Semaglutide should be stopped at least two months before a planned pregnancy, per the product labeling and MotherToBaby. If pregnancy is the reason you’re stopping, that’s a firm medical reason, and the plan looks different.
• Upcoming surgery. These drugs slow stomach emptying, and there are reports of aspiration under anesthesia. Tell your surgeon and anesthesiologist you’re on one, even if you’ve recently stopped.
• If you miss doses and want to restart. The Wegovy labeling says that after two or more missed consecutive doses you can resume as scheduled, or restart the dose escalation from a lower step, which usually means less nausea. Don’t quietly double up.

The first month after your last dose

What you do in the four weeks after stopping Ozempic or Wegovy sets the pattern for the next year. Here’s the sequence I’d suggest.

1. Week 1: set your line in the sand. Weigh yourself and write the number down. Pick your trigger weight, usually about 5 pounds above it. That’s the number that triggers a phone call, not a shrug.
2. Week 1: lock in protein. Hit your gram target every day starting now, while your appetite is still quiet. Eggs, Greek yogurt, dal, paneer, fish, chicken, cottage cheese. Protein first at every meal.
3. Week 2: start strength training before you need it. Three sessions a week, all major muscle groups. Begin while the medication is still partly in your system and training feels manageable.
4. Weeks 2 to 4: expect hunger to climb and plan for it. This is when appetite returns. Keep the trigger foods out of the house, keep meals on a schedule, and don’t go long stretches without eating or you’ll overshoot at dinner.
5. Week 4: book the follow-up. See your doctor roughly a month out, with your weight log. Recheck blood pressure and blood sugar if you have diabetes or hypertension.
6. Any time: act on the trigger, fast. Hit your trigger weight and call. Restarting at a low dose after 8 pounds of regain is a much easier conversation than after 30.

The single best predictor of holding your loss is how quickly you respond to early regain. Patients who call at 5 pounds do well. Patients who wait until they’re back where they started have to begin again, including the dose escalation and the nausea.

When to call your doctor

Get in touch sooner rather than later if you notice any of these after stopping:

• Regain of 5 pounds or more that keeps climbing week over week
• Blood sugar readings drifting up, if you have diabetes or prediabetes
• Blood pressure climbing back toward where it was
• Food thoughts becoming constant or hard to manage again
• Low mood, or feeling defeated about your weight, which is common after regain and worth saying out loud

Frequently asked questions

Will I gain all the weight back after stopping Ozempic?

Not necessarily, and the averages hide a lot of variation. Clinical trials show roughly two-thirds of lost weight returning within a year. But in Cleveland Clinic’s real-world study of nearly 8,000 patients, average regain was only 0.5 percent of body weight at one year, and 45 percent of people held steady or kept losing. The difference came down to what they did next.

How fast does the weight come back after stopping Ozempic?

Faster than most people expect. The BMJ analysis found about 0.8 kg per month after semaglutide or tirzepatide, which is close to 2 pounds a month. It usually starts within the first couple of months as appetite returns, since semaglutide takes about six weeks to clear your system.

Can I just take a lower dose instead of stopping?

For many people, yes, and this is the most underused option in the whole conversation. The SURMOUNT-MAINTAIN trial found that stepping tirzepatide down to 5 mg held about 70 percent of the weight loss over the following year, compared with much larger regain on placebo. Interval dosing, meaning longer gaps between injections, is another approach your doctor may consider. Don’t adjust your own dose without talking it through first.

Do diet and exercise keep the weight off after stopping?

They change your body composition for the better, and they’re worth doing. What the evidence doesn’t show is that they prevent regain on their own. The BMJ meta-analysis found behavioral support did not slow the rate of regain after medication stopped. Build the habits while you’re still on treatment, and treat them as muscle protection rather than as a replacement for the medication.

Does stopping Ozempic cause withdrawal symptoms?

There’s no withdrawal syndrome the way there is with some medications, and no physical danger in stopping. What returns is appetite, along with the gradual loss of the blood sugar, blood pressure, and cholesterol improvements you gained. Nausea and other digestive side effects usually improve after stopping.

Resources

• The BMJ: Weight regain after cessation of medication for weight management, systematic review and meta-analysis, January 2026
• Cleveland Clinic: What happens when patients stop taking GLP-1 drugs, real-world analysis of 7,938 patients
• American Family Physician: Long-term use of obesity management medications and discontinuation strategies
• Nutritional priorities to support GLP-1 therapy for obesity, joint advisory published in Obesity, 2025
• NIDDK: Weight management resources
• CDC: Physical activity guidelines for adults

This article is for education and does not replace medical advice. Never start, stop, or change the dose of a prescription medication without talking to your own physician.